About this trial
This clinical trial aims to construct and apply a collaborative network database for gastric cancer in Hebei Province, driven by artificial intelligence (AI) technology. The project seeks to integrate clinical data, genomic information, and treatment outcomes from multiple hospitals and research centers within the region. By leveraging advanced AI algorithms, the database will facilitate comprehensive data analysis to identify novel biomarkers, optimize therapeutic strategies, and improve patient outcomes. This initiative will also support real-time data sharing and collaboration among healthcare providers, researchers, and policymakers, ultimately enhancing the overall management and treatment of gastric cancer in Hebei Province.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
All patients with gastric cancer
Trial design
Cohort
Retrospective
Treatments tested in this trial
Gastric Cancer AI-driven Data Integration Genomic Analysis Biomarker
Diagnostic testEnter the clinical and related test, examination and treatment information of all gastric cancer patients, and find risk factors that affect the prognosis
Treatment groups
Trial outcomes
Primary outcomes
5-year overall survival
5-year overall survival
Secondary outcomes
5-year recurrence-free survival
5-year recurrence-free survival
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Qun Zhao
Lead sponsor
Hebei Medical University
Sponsor institution